These data suggest the possibility that PLD1/mTOR signalling plays a role in the growth of high-grade tumours; and a larger study evaluating the expression of these proteins with tumour grade and patient prognosis is clearly warranted. The gene discussed is PLD1; the disease is neoplasm.